Related Experiment Videos
Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
1Department of Psychological Medicine, St. Bartholomew's Hospital, London, U.K.
The Journal of Clinical Psychiatry
|January 1, 1996
Summary
Major depression involves noradrenergic and serotonergic abnormalities. This theory links stress via the hypothalamic-pituitary-adrenal axis to these monoamine disturbances, involving cortisol hypersecretion and brain receptors.
Area of Science:
- Neuroscience
- Psychiatry
- Endocrinology
Background:
- Major depression is associated with abnormalities in noradrenergic (NE) and serotonergic (5-HT) neurotransmission.
- Current antidepressants, like tricyclics, target NE and 5-HT reuptake.
- Advances in understanding 5-HT and NE receptor systems are driving the development of novel therapeutics.
Purpose of the Study:
- To propose a theoretical framework linking stress to monoamine dysfunction in major depression.
- To elucidate the role of the hypothalamic-pituitary-adrenal (HPA) axis in mood disorders.
Main Methods:
- Theoretical review and synthesis of existing research.
- Examination of the HPA axis's influence on neurotransmitter systems.
- Exploration of cortisol's direct and indirect effects on brain function.
Main Results:
- The HPA axis, particularly stress-induced cortisol hypersecretion, is implicated in disrupting monoamine pathways.
- Cortisol receptors within the brain are suggested as a key mechanism mediating these changes.
- This pathway offers a potential explanation for the neurobiological underpinnings of depression.
Conclusions:
- Stress-related HPA axis dysregulation, involving cortisol, may be a central factor in major depression.
- Targeting the HPA axis and cortisol pathways could represent a novel therapeutic strategy.
- Further research is warranted to validate the proposed mechanisms of cortisol action on monoamine systems.